ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,459.10
1.11%
US Tech 100
18,527.20
1.07%
다우존스 지수
40,589.34
1.64%
Bitcoin
67,934.75
3.26%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Vaccinex Inc (VCNX)

  7. Vaccinex Inc (VCNX) 뉴스

VCNX Vaccinex Inc

6.7501
-0.1499 (-2.17%)
시간외 거래
최종 업데이트: 07:03:45
15분 지연
기업명 주식 심볼 시장 주식 타입
Vaccinex Inc VCNX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.1499 -2.17% 6.7501 07:03:45
개장가 저가 고가 종가 전일 종가
7.05 6.63 7.10 6.72 6.90
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/07/202421:00GLOBEVaccinex to report topline data for SIGNAL-AD Phase 1b/2..
09/07/202405:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/07/202413:15EDGAR2Form EFFECT - Notice of Effectiveness
06/06/202421:36EDGAR2Form 8-K - Current report
06/06/202421:30GLOBEVaccinex Reports Completion of Last Patient Visit in..
01/06/202405:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/05/202407:00GLOBEVaccinex Reports First Quarter 2024 Financial Results and..
16/05/202406:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/05/202405:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/05/202405:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/05/202405:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/05/202405:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/05/202401:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/05/202406:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/05/202405:16EDGAR2Form 8-K - Current report
09/05/202401:29EDGAR2Form S-3/A - Registration statement under Securities Act of..
02/04/202421:30GLOBEVaccinex Reports 2023 Financial Results and Provides..
27/03/202421:30GLOBEVaccinex, Inc. Announces $1.5 Million Registered Direct..
05/03/202406:19EDGAR2Form 8-K - Current report
22/02/202400:10EDGAR2Form 8-K - Current report
21/02/202422:00GLOBEVaccinex Announces Multiple New Agreements for Access to..
15/02/202422:06EDGAR2Form 8-K - Current report
15/02/202422:00GLOBEVaccinex, Inc. Announces Reverse Stock Split
14/02/202406:30EDGAR2Form 8-K - Current report
14/02/202406:15EDGAR2Form SC 13D/A - General statement of acquisition of..
13/02/202406:22EDGAR2Form SC 13D/A - General statement of acquisition of..
10/02/202406:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/02/202422:20EDGAR2Form 8-K/A - Current report: [Amend]
08/02/202405:43EDGAR2Form 8-K - Current report
07/02/202422:00GLOBEVaccinex Announces Pricing of $3.7 Million PIPE Financing
20/01/202406:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/01/202407:16EDGAR2Form S-3 - Registration statement under Securities Act of..
09/01/202406:16EDGAR2Form DEF 14A - Other definitive proxy statements
29/12/202306:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202306:15EDGAR2Form PRE 14A - Other preliminary proxy statements
13/12/202306:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:00GLOBENasdaq Grants Vaccinex Extension Until March 4, 2024 to..
13/11/202322:00GLOBEVaccinex Reports Third Quarter 2023 Financial Results and..
13/11/202321:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202305:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202322:00GLOBEVaccinex Reports Clinical Benefit in Interim Analyses from..
26/10/202322:30EDGAR2Form 8-K - Current report
26/10/202322:30GLOBEVaccinex Reports Positive Effect of Pepinemab Treatment on..
26/10/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202305:15EDGAR2Form SC 13D/A - General statement of acquisition of..
14/10/202305:54EDGAR2Form 8-K - Current report
13/10/202305:30EDGAR2Form SC 13D/A - General statement of acquisition of..
06/10/202305:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
VCNX
Vaccinex
BIT
ANIM
Anima
TSXV
ARU.RT
Aurania Resources
ASX
ANO
Advance ZincTek
BIT
S27021
Societe Generale Effekten
BIT
P1SR27
BNP Paribas Issuance
BIT
P1P712
BNP Paribas Issuance
FX
NOKSGD
NOK vs SGD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유